Welcome to our dedicated page for Bayview Acquisition SEC filings (Ticker: BAYA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Bayview Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Bayview Acquisition's regulatory disclosures and financial reporting.
Bayview Acquisition Corp deposited $50,000 into its trust account on May 15, 2026 to obtain a one‑month extension of the deadline to complete its initial business combination, moving it from May 19, 2026 to June 19, 2026.
This is the sixth and final extension allowed under the company’s current Second Amended and Restated Articles of Association.
Mizuho Financial Group reported beneficial ownership of 245,564 common shares of Bayview Acquisition Corp, representing 9.0% of the class as of 03/31/2026. The filing states sole voting and sole dispositive power over 245,564 shares and notes indirect ownership through a wholly owned subsidiary.
Bayview Acquisition Corp is asking shareholders to approve three proposals at a May 28, 2026 extraordinary general meeting. The main goal is to extend the deadline to complete a Business Combination from June 19, 2026 to December 19, 2026, with up to six one‑month extensions funded by $50,000 monthly deposits into the trust account.
Public shareholders can redeem their shares for cash in connection with the vote. As of the record date, the redemption price was approximately $12.03 per Public Share, based on about $12.1 million held in the Trust Account, versus a $12.00 Nasdaq trading price. If the extensions are not approved and no deal closes by June 19, 2026, Bayview will redeem all Public Shares and liquidate.
Bayview Acquisition Corp is asking shareholders to approve amendments that would extend the deadline to complete a Business Combination from June 19, 2026 to December 19, 2026 and permit up to six one-month extensions. Shareholders may redeem Public Shares for a pro rata portion of the Trust Account if the Extension is implemented.
The proposals include (i) an Extension Amendment to the charter, (ii) a Trust Agreement Amendment to allow monthly $50,000 extension payments in exchange for non-interest bearing promissory notes, and (iii) an adjournment proposal. There are 2,738,292 Ordinary Shares outstanding; Sponsors hold 1,732,500 Founder Shares.
Bayview Acquisition Corp received a favorable decision from a Nasdaq Hearings Panel allowing its shares, units and rights to remain listed, with trading moved from the Nasdaq Global Market to the Nasdaq Capital Market effective April 24, 2026.
The extension is conditional. Bayview must close its proposed business combination with Oabay Inc. and meet Nasdaq’s initial listing standards by June 19, 2026, while also complying with ongoing listing rules. Failure to satisfy these conditions could still lead to delisting despite the current exception.
Bayview Acquisition Corp deposited $50,000 into its trust account to extend the deadline to complete its initial business combination. This payment moves the cutoff date from April 19, 2026 to May 19, 2026, providing one additional month to close a deal.
The company states this is the fifth of up to six permitted extensions under its Second Amended and Restated Articles of Association.
Bayview Acquisition Corp reported the results of its annual general meeting of shareholders held on April 10, 2026. Shareholders approved all matters presented, as described in the company’s definitive proxy statement filed on March 23, 2026.
A total of 2,738,292 ordinary shares were entitled to vote as of March 2, 2026, and holders of 2,274,294 shares were present in person or by proxy, representing 83.05% of eligible shares. One item received 2,184,194 votes in favor, with 90,100 broker non-votes, indicating that each proposal passed with strong shareholder support.
Bayview Acquisition Corp reports additional Nasdaq listing problems that heighten its delisting risk. The company previously received a determination to delist its securities and has applied to move from The Nasdaq Global Market to The Nasdaq Capital Market, but that transfer is still pending approval.
Bayview has now been notified it is out of compliance with Nasdaq Listing Rule 5450(b)(2)(B), which requires at least 1,100,000 publicly held shares. A hearing before a Nasdaq Hearings Panel is scheduled for March 31, 2026, where the company plans to address this and other deficiencies, though there is no assurance it will regain compliance or avoid delisting.
Bayview Acquisition Corp, a Cayman Islands SPAC, is asking shareholders to approve routine annual matters at an April 10, 2026 meeting. Proposals include re-electing Class I director John Joseph DeVito for a three-year term, ratifying UHY LLP as auditor for 2026, and allowing potential adjournment if votes are insufficient.
The meeting will be held in Houston and via webcast, with one vote per ordinary share and a one-third quorum requirement. Sponsors, directors, officers and affiliates control about 1,732,500 shares, or roughly 50% of outstanding ordinary shares, meaning no public shares are needed to pass any of the proposals if all shares are present.
Bayview remains a pre-revenue blank check company focused on completing an initial business combination, primarily targeting Asia. It has already signed a definitive agreement for a business combination and will seek separate shareholder approval in a future proxy statement. The proxy also highlights SPAC-specific regulatory, investment company, CFIUS and Nasdaq listing-compliance risks.